Myriad Genetics Inc. Q2 Income Advances

Shutterstock photo

(RTTNews.com) - Myriad Genetics Inc. ( MYGN ) released earnings for its second quarter that gained ground from last year.

The company said its bottom line came in at $22.3 million, or $0.31 per share. This was higher than $17.5 million, or $0.26 per share, in last year's second quarter.

Analysts had expected the company to earn $0.24 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter fell 1.3% to $194.0 million. This was down from $196.5 million last year.

Myriad Genetics Inc. earnings at a glance:

-Earnings (Q2): $22.3 Mln. vs. $17.5 Mln. last year.
-Earnings Growth (Y-o-Y): 27.4%
-EPS (Q2): $0.31 vs. $0.26 last year.
-EPS Growth (Y-o-Y): 19.2%
-Analysts Estimate: $0.24
-Revenue (Q2): $194.0 Mln vs. $196.5 Mln last year.
-Revenue Change (Y-o-Y): -1.3%


Next quarter EPS guidance: $0.26-$0.28
Next quarter revenue guidance: $186-$188 Mln
Full year EPS guidance: $1.11-$1.16
Full year revenue guidance: $760-$770 Mln

For comments and feedback: contact editorial@rttnews.com


This article appears in: Fundamental Analysis , World Markets , Stocks , Earnings
Referenced Symbols: MYGN ,

More from RTT News


See All RTT news

Research Brokers before you trade

Want to trade FX?